136 related articles for article (PubMed ID: 37596162)
1. Anti-parietal cell antibodies as a potential biomarker for interstitial lung disease associated with primary Sjögren's syndrome.
Zhang N; Wang H; Sun W; Hou H; Du J; Xu J; Wei W
Med Clin (Barc); 2024 Jan; 162(1):1-8. PubMed ID: 37596162
[TBL] [Abstract][Full Text] [Related]
2. Sjögren's syndrome-associated interstitial lung disease: A multicenter study.
Reina D; Roig Vilaseca D; Torrente-Segarra V; Cerdà D; Castellví I; Díaz Torné C; Moreno M; Narváez J; Ortiz V; Blavia R; Martín-Baranera M; Corominas H
Reumatol Clin; 2016; 12(4):201-5. PubMed ID: 26573882
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and risk factors for primary Sjögren's syndrome combined with interstitial lung disease: a retrospective study.
Yang Z; Zhao H; Shan L; Wang D
Acta Biochim Pol; 2024; 71():12461. PubMed ID: 38721305
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.
Zhang T; Yuan F; Xu L; Sun W; Liu L; Xue J
Clin Rheumatol; 2020 May; 39(5):1561-1568. PubMed ID: 31902032
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.
Dong X; Zhou J; Guo X; Li Y; Xu Y; Fu Q; Lu Y; Zheng Y
Clin Rheumatol; 2018 Nov; 37(11):2981-2988. PubMed ID: 30242640
[TBL] [Abstract][Full Text] [Related]
6. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of interstitial lung disease associated with primary Sjögren's syndrome.
Weng L; Chen Y; Liang T; Lin Y; Liu D; Yu C; Hu Y; Lui W; Liu Y; Chen X; Li Q; Ge S; Ascherman DP; Chen J
Eur J Med Res; 2022 Oct; 27(1):199. PubMed ID: 36217184
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome.
Buvry C; Cassagnes L; Tekath M; Artigues M; Pereira B; Rieu V; Le Guenno G; Tournadre A; Ruivard M; Grobost V
Respir Med; 2020 Mar; 163():105895. PubMed ID: 32056839
[TBL] [Abstract][Full Text] [Related]
9. Respiratory infection risk in primary Sjögren's syndrome complicated with interstitial lung disease: a retrospective study.
Zhou X; Li H; Wang N; Jin Y; He J
Clin Rheumatol; 2024 Feb; 43(2):707-715. PubMed ID: 38091126
[TBL] [Abstract][Full Text] [Related]
10. Circulating Th2 cell reduction and Th1/Th2 imbalance are correlated with primary Sjogren's syndrome-associated interstitial lung disease.
Shi L; Wang J; Guo HX; Han XL; Tang YP; Liu GY
Arthritis Res Ther; 2022 May; 24(1):121. PubMed ID: 35606782
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
[TBL] [Abstract][Full Text] [Related]
12. Predicting the risk of interstitial lung disease in patients with primary Sjögren's syndrome: Novel nomogram and elevated Th2 cells.
Wang Y; Jia Y; Qin Y; Feng M; Liang Z; Zhao X; Gao C; Guo H; Luo J
Mol Immunol; 2024 Apr; 168():25-37. PubMed ID: 38382243
[TBL] [Abstract][Full Text] [Related]
13. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.
He SH; He YJ; Guo KJ; Liang X; Li SS; Li TF
Clin Rheumatol; 2022 Apr; 41(4):1153-1161. PubMed ID: 34757493
[TBL] [Abstract][Full Text] [Related]
15. Clinical course and risk factors for development and progression of interstitial lung disease in primary Sjögren's syndrome.
Lee KA; Nam BD; Hwang JH; Kim HS
Sci Rep; 2023 Jun; 13(1):9189. PubMed ID: 37280251
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.
Enomoto Y; Takemura T; Hagiwara E; Iwasawa T; Fukuda Y; Yanagawa N; Sakai F; Baba T; Nagaoka S; Ogura T
PLoS One; 2013; 8(9):e73774. PubMed ID: 24040065
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.
Shi L; Fu Q; Chen N; Liu R; Zheng Y
Clin Exp Med; 2020 Aug; 20(3):393-399. PubMed ID: 32253547
[TBL] [Abstract][Full Text] [Related]
18. Serum bilirubin levels in primary Sjögren's syndrome: an association with interstitial lung disease.
Peng YF; Lu FY; Ma LY
BMC Pulm Med; 2023 Sep; 23(1):366. PubMed ID: 37777728
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and prognosis of interstitial lung disease for primary Sjögren syndrome patients: A retrospective case‒control study.
Huang Y; Qiu Y; Xie Z; Zhang F; Zhang Y; Guan M; Wang X; Cai W; Sun J
Clin Rheumatol; 2023 Nov; 42(11):3033-3041. PubMed ID: 37421537
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Kamiya Y; Fujisawa T; Kono M; Nakamura H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Sumikawa H; Johkoh T; Yasui H; Hozumi H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
Respir Med; 2019 Nov; 159():105811. PubMed ID: 31710871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
